Edesa Biotech Inc./$EDSA
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
Ticker
$EDSA
Sector
Primary listing
Employees
17
Headquarters
Markham, Canada
Website
EDSA Metrics
BasicAdvanced
$61m
-
-$1.37
1.07
-
Price and volume
Market cap
$61m
Beta
1.07
52-week high
$20.32
52-week low
$0.72
Average daily volume
330k
Financial strength
Current ratio
4.761
Quick ratio
4.671
Profitability
EBITDA (TTM)
-10.909
Effective tax rate (TTM)
-0.01%
Management effectiveness
Return on assets (TTM)
-47.73%
Return on equity (TTM)
-81.16%
Valuation
Price to book
33.55
Price to tangible book (TTM)
-581.92
Price to free cash flow (TTM)
-6.99
Free cash flow yield (TTM)
-14.31%
Free cash flow per share (TTM)
-0.984
Growth
Earnings per share change (TTM)
-11.69%
3-year earnings per share growth (CAGR)
-36.45%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs